SULFABID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulfabid, and what generic alternatives are available?
Sulfabid is a drug marketed by Pharm Res Assoc and Purdue Frederick and is included in two NDAs.
The generic ingredient in SULFABID is sulfaphenazole. Additional details are available on the sulfaphenazole profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULFABID?
- What are the global sales for SULFABID?
- What is Average Wholesale Price for SULFABID?
Summary for SULFABID
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 93 |
| Patent Applications: | 1,607 |
| DailyMed Link: | SULFABID at DailyMed |
US Patents and Regulatory Information for SULFABID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharm Res Assoc | SULFABID | sulfaphenazole | SUSPENSION;ORAL | 013093-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Purdue Frederick | SULFABID | sulfaphenazole | TABLET;ORAL | 013092-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
